Company
United StatesPublic company, NYSE: AAgilent Technologies Inc (NYSE: A), Boulder, CO – FDA Inspections
Inspection records and compliance data for Agilent Technologies Inc in Boulder, Colorado. 3 FDA inspections on record, 1 Form 483, last inspected May 06, 2026. Publicly traded as NYSE: A.
Company Profile
This profile covers Agilent Technologies Inc based in Boulder, Colorado, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Unclassified
- 2
- Form 483s
- 1
- Warning letters
- 0
First inspected February 21, 2018. Last inspected May 6, 2026.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 6, 2026 | Not classified | Human Drugs | 1319444 |
| August 2, 2019 | VAI | Human Drugs · Drug Quality Assurance | 1098600 |
| February 21, 2018 | Not classified | Human Drugs | 1045456 |
FDA documents
Form 483s (1)
EIRs (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Agilent Technologies Inc
Stock ticker
A
Exchange
NYSE
Share price
$173.04
Market cap
$48.8B
Price as of
November 13, 2026
FEI Number
3007057070
Address
5555 Airport Blvd, Boulder, Colorado 80301, United States
Country
United States
ID: 865fe026-9db0-4e3e-bc4a-e0d25b465093